P.M. Nilsson

465 total citations
14 papers, 245 citations indexed

About

P.M. Nilsson is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, P.M. Nilsson has authored 14 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Cardiology and Cardiovascular Medicine and 3 papers in Epidemiology. Recurrent topics in P.M. Nilsson's work include Adipokines, Inflammation, and Metabolic Diseases (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers) and Peripheral Artery Disease Management (2 papers). P.M. Nilsson is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers) and Peripheral Artery Disease Management (2 papers). P.M. Nilsson collaborates with scholars based in Sweden, Denmark and Qatar. P.M. Nilsson's co-authors include Gunnar Engström, Gerd Östling, Margaretha Persson, Bo Hedblad, Maria Rosvall, Olle Melander, Kenneth M. Persson, Jan Cederholm, Björn Eliasson and Lars Lindholm and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Atherosclerosis.

In The Last Decade

P.M. Nilsson

14 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P.M. Nilsson Sweden 7 103 50 45 36 32 14 245
Hongxuan Fan China 7 93 0.9× 75 1.5× 68 1.5× 24 0.7× 29 0.9× 25 235
Chongjin Wang China 6 61 0.6× 42 0.8× 100 2.2× 30 0.8× 29 0.9× 10 292
Pan Wei United States 3 56 0.5× 65 1.3× 25 0.6× 24 0.7× 39 1.2× 4 387
Eirini Pagkalidou Greece 11 73 0.7× 35 0.7× 34 0.8× 30 0.8× 37 1.2× 32 266
Viktor Peršić Croatia 11 79 0.8× 17 0.3× 45 1.0× 56 1.6× 50 1.6× 46 315
Rüştü Serter Türkiye 11 45 0.4× 123 2.5× 53 1.2× 79 2.2× 53 1.7× 23 344
Christos Georgakopoulos Greece 9 88 0.9× 27 0.5× 14 0.3× 35 1.0× 20 0.6× 26 198
Sang-Hee Jung South Korea 11 88 0.9× 61 1.2× 86 1.9× 63 1.8× 55 1.7× 13 326
Jaime Sanz‐Cánovas Spain 10 46 0.4× 89 1.8× 42 0.9× 45 1.3× 32 1.0× 27 264
Volkan Noyan Türkiye 12 98 1.0× 101 2.0× 20 0.4× 66 1.8× 19 0.6× 31 414

Countries citing papers authored by P.M. Nilsson

Since Specialization
Citations

This map shows the geographic impact of P.M. Nilsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.M. Nilsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.M. Nilsson more than expected).

Fields of papers citing papers by P.M. Nilsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.M. Nilsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.M. Nilsson. The network helps show where P.M. Nilsson may publish in the future.

Co-authorship network of co-authors of P.M. Nilsson

This figure shows the co-authorship network connecting the top 25 collaborators of P.M. Nilsson. A scholar is included among the top collaborators of P.M. Nilsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.M. Nilsson. P.M. Nilsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Larsson, Anna, Ulrika Ericson, Daniel Jönsson, et al.. (2024). New connections of medication use and polypharmacy with the gut microbiota composition and functional potential in a large population. Scientific Reports. 14(1). 23723–23723. 6 indexed citations
2.
Nilsson, P.M., Gerd Östling, Cecilia Kennbäck, & Mats A. A. Persson. (2016). [PP.12.11] ENDOTHELIAL FUNCTION IN YOUNG HEALTHY SUBJECTS. Journal of Hypertension. 34(Supplement 2). e187–e187. 3 indexed citations
3.
Maccallini, Gustavo, Martín Koretzky, Felipe Inserra, et al.. (2016). [OP.3D.03] ASSOCIATION BETWEEN NEUTROPHIL TO LYMPHOCYTE RATIO AND ARTERIAL STIFFNESS IN A POPULATION SAMPLE. Journal of Hypertension. 34(Supplement 2). e33–e33. 1 indexed citations
4.
Rosvall, Maria, Margaretha Persson, Gerd Östling, et al.. (2015). Risk factors for the progression of carotid intima-media thickness over a 16-year follow-up period: The Malmö Diet and Cancer Study. Atherosclerosis. 239(2). 615–621. 105 indexed citations
5.
6.
Khalili, Pantea, Allan Flyvbjerg, Jan Frystyk, et al.. (2010). Total adiponectin does not predict cardiovascular events in middle-aged men in a prospective, long-term follow-up study. Diabetes & Metabolism. 36(2). 137–143. 17 indexed citations
7.
Lohmander, Stefan, et al.. (2008). 324 INCIDENCE OF SEVERE KNEE AND HIP OSTEOARTHRITIS IN RELATION TO DIFFERENT MEASURES OF BODY MASS — A POPULATION-BASED PROSPECTIVE COHORT STUDY. Osteoarthritis and Cartilage. 16. S143–S143. 13 indexed citations
8.
Gast, G C de, D.E. Grobbee, Victor J.M. Pop, et al.. (2008). Vasomotor symptoms are associated with a lower bone mineral density.. Research portal (Tilburg University). 1 indexed citations
9.
Borgquist, Rasmus, Margrét Leósdóttir, P.M. Nilsson, & Ronnie Willenheimer. (2007). Self-rated health and classical risk factors for coronary heart disease predict development of erectile dysfunction 25 years later. International Journal of Clinical Practice. 62(2). 206–213. 3 indexed citations
10.
Gottsäter, Anders, et al.. (2006). Are there differences of inflammatory bio-markers between diabetic and non-diabetic patients with critical limb ischemia?. PubMed. 25(4). 370–7. 13 indexed citations
11.
Nilsson, P.M., Soffia Guðbjörnsdóttir, Björn Eliasson, & Jan Cederholm. (2003). Hypertension in diabetes: trends in clinical control in repeated large-scale national surveys from Sweden. Journal of Human Hypertension. 17(1). 37–44. 34 indexed citations
12.
Nilsson, P.M. & Stig Attvall. (2001). [Angiotensin II receptor antagonists reduce the development of nephropathies in type 2 diabetes. Three new studies are of interest, but don't answer all questions].. PubMed. 98(45). 4960–2. 1 indexed citations
13.
Nilsson, P.M., et al.. (2000). Combined Seropositivity forH. PyloriandC. Pneumoniaeis Associated with Age, Obesity and Social Factors. European Journal of Cardiovascular Prevention & Rehabilitation. 7(3). 191–195. 45 indexed citations
14.
Nilsson, P.M., Stig Attvall, & Mats Eliasson. (1998). [More active therapy in diabetes type 2 is justified by findings in a break-through study. 20-year follow-up of over 5000 patients].. PubMed. 95(45). 4983–4, 4987. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026